Genetesis is an American medical technology service provider focused on medical imaging that redefines the detection of myocardial ischemia and coronary artery disease by combining non-invasive biomagnetic imaging technology with cloud-based web services and machine learning capabilities. Standard of Care for Diagnosing Cardiovascular Disease in Outpatient and Acute Care Settings. Genetesis recently announced that it has completed a $17.5 million Series C financing. The round was led by Mithril Capital, with participation from Cercano Management, JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech.
This article is reproduced from: https://www.itjuzi.com/investevent/13590673
This site is for inclusion only, and the copyright belongs to the original author.